The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sequential intravesical gemcitabine and docetaxel versus bacillus Calmette-Guérin for the treatment of high-risk, treatment-naïve, non-muscle invasive bladder cancer.
 
Ian M. McElree
No Relationships to Disclose
 
Ryan L. Steinberg
Patents, Royalties, Other Intellectual Property - Patent holder - Patent 16/862532: Neurogenic Bladder Monitoring and Associated Systems and Devices; Patent holder - Patent 16/862532: Neurogenic Bladder Monitoring and Associated Systems and Devices
 
Sarah L. Mott
No Relationships to Disclose
 
Michael A. O'Donnell
Consulting or Advisory Role - BioCancell; Bioniche Life Sciences; Merck/Schering Plough; SonaCare Medical; Theralase; Viventia Biotech
Travel, Accommodations, Expenses - Bioniche Life Sciences
 
Vignesh T. Packiam
Honoraria - CG Oncology